The effect of tiotropium on the pulmonary diffusing capacity

U. Gonlugur, T. Gonlugur (Sivas, Turkey)

Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology II
Session: Miscellaneous pulmonary pharmacology II
Session type: Electronic Poster Discussion
Number: 4543
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Gonlugur, T. Gonlugur (Sivas, Turkey). The effect of tiotropium on the pulmonary diffusing capacity. Eur Respir J 2007; 30: Suppl. 51, 4543

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The effect of salbutamol on pulmonary diffusing capacity
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019


The effect of tiotropium on lung dynamic hyperinflation and treadmill exercise capacity in mild to moderate COPD
Source: Annual Congress 2012 - COPD treatments: efficacy and safety
Year: 2012

Effect of inhaled bronchodilators on inspiratory capacity and dyspnoea at rest in COPD
Source: Eur Respir J 2003; 21: 86-94
Year: 2003



Differentiation of bronchodilator effects of indacaterol and formoterol by FEV1 and inspiratory capacity (IC) in patients with COPD
Source: Annual Congress 2007 - New drugs for COPD
Year: 2007



Effects of tiotropium and salmeterol/fluticasone combination on lung hyperinflation, dyspnea and exercise tolerance in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 33s
Year: 2006

Insulin therapy preserves pulmonary diffusing capacity
Source: Eur Respir J 2005; 26: Suppl. 49, 687s
Year: 2005

The role of spirometry and ?arbon monoxide diffusing capacity (DLCO) in the diagnosis of pulmonary function in patients after COVID-19 pneumonia
Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era
Year: 2021


The effects of extrafine beclomethasone/formoterol on hyperinflation and airway geometry in COPD patients
Source: Annual Congress 2012 - The best of pharmacology treatment for asthma and COPD
Year: 2012


Diffusing capacity and oxygen saturation response to bronchodilation in patients with severe COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 600s
Year: 2007

Improvements in inspiratory capacity with tiotropium in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 491s
Year: 2002

No effect of baseline diffusing capacity of lung for carbon monoxide on benefit of nintedanib
Source: International Congress 2016 – IPF treatment II
Year: 2016



The effects of lung volume reduction treatment on diffusing capacity and gas exchange
Source: Eur Respir Rev, 29 (158) 190171; 10.1183/16000617.0171-2019
Year: 2020



ACE-inhibition improves peak exercise oxygen uptake and ventilation in COPD: an effect unrelated to pulmonary function
Source: Eur Respir J 2003; 22: Suppl. 45, 205s
Year: 2003

The effect of different bronchodilator drugs on pulmonary function tests, exercise capacity and quality of life in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 515s
Year: 2005

Replacing oxytropium with tiotropium significantly improves pulmonary function in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 213s
Year: 2006

Effect of heliox on exercise capacity in COPD
Source: ERS Course 2017
Year: 2017

The effects of sildenafil on lung function in COPD
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Effect of cilomilast on trapped gas volume and indices of hyperinflation in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 438s
Year: 2003

Comparative effects of formoterol monotherapy versus formoterol plus tiotropium on dynamic hyperinflation and exercise tolerance in COPD
Source: Annual Congress 2009 - Influence of interventions and comorbidity on exercise performance
Year: 2009



Effect of He-O2 breathing and inhaled salbutamol on expiratory flow limitation and dynamic hyperinflation in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 197s
Year: 2002